W Bradford Smith - Net Worth and Insider Trading
W Bradford Smith Net Worth
The estimated net worth of W Bradford Smith is at least $738 dollars as of 2024-04-27. W Bradford Smith is the See Remarks of Homology Medicines Inc and owns about 790 shares of Homology Medicines Inc (FIXX) stock worth over $738. Details can be seen in W Bradford Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that W Bradford Smith has not made any transactions after 2023-01-09 and currently still holds the listed stock(s).
Transaction Summary of W Bradford Smith
W Bradford Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, W Bradford Smith owns 4 companies in total, including Lyra Therapeutics Inc (LYRA) , Homology Medicines Inc (FIXX) , and Ocular Therapeutix Inc (OCUL) among others .
Click here to see the complete history of W Bradford Smith’s form 4 insider trades.
Insider Ownership Summary of W Bradford Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LYRA | Lyra Therapeutics Inc | 2020-04-30 | director |
| FIXX | Homology Medicines Inc | 2023-01-09 | CFO & Treasurer & Secretary |
| OCUL | Ocular Therapeutix Inc | 2016-02-02 | See Remarks |
| NURO | NeuroMetrix Inc | 2005-02-14 | Chief Financial Officer |
W Bradford Smith Latest Holdings Summary
W Bradford Smith currently owns a total of 1 stock. W Bradford Smith owns 790 shares of Homology Medicines Inc (FIXX) as of January 9, 2023, with a value of $738.
Latest Holdings of W Bradford Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FIXX | Homology Medicines Inc | 2023-01-09 | 790 | 0.93 | 738 |
Holding Weightings of W Bradford Smith
W Bradford Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, W Bradford Smith has made a total of 11 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Homology Medicines Inc is the sale of 207 shares on January 9, 2023, which brought W Bradford Smith around $5,183.
Insider Trading History of W Bradford Smith
- 1
W Bradford Smith Trading Performance
W Bradford Smith Ownership Network
Ownership Network List of W Bradford Smith
Ownership Network Relation of W Bradford Smith
W Bradford Smith Owned Company Details
What does Lyra Therapeutics Inc do?
Who are the key executives at Lyra Therapeutics Inc?
W Bradford Smith is the director of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and 10 percent owner Nbvm Gp, Llc .
Lyra Therapeutics Inc (LYRA) Insider Trades Summary
Over the past 18 months, W Bradford Smith made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.
Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lyra Therapeutics Inc Insider Transactions
W Bradford Smith Mailing Address
Above is the net worth, insider trading, and ownership report for W Bradford Smith. You might contact W Bradford Smith via mailing address: C/o Homology Medicines, Inc., One Patriots Park, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
